Sucampo Pharmaceuticals, Inc.
(SCMP)
- CAPS Rating:
-
An emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body.